» Articles » PMID: 28613921

High-Attenuation Areas on Chest Computed Tomography and Clinical Respiratory Outcomes in Community-Dwelling Adults

Abstract

Rationale: Areas of increased lung attenuation visualized by computed tomography are associated with all-cause mortality in the general population. It is uncertain whether this association is attributable to interstitial lung disease (ILD).

Objectives: To determine whether high-attenuation areas are associated with the risk of ILD hospitalization and mortality in the general population.

Methods: We performed a cohort study of 6,808 adults aged 45-84 years sampled from six communities in the United States. High-attenuation areas were defined as the percentage of imaged lung volume with attenuation values between -600 and -250 Hounsfield units. An adjudication panel determined ILD hospitalization and death.

Measurements And Main Results: After adjudication, 52 participants had a diagnosis of ILD during 75,232 person-years (median, 12.2 yr) of follow-up. There were 48 hospitalizations attributable to ILD (crude rate, 6.4 per 10,000 person-years). Twenty participants died as a result of ILD (crude rate, 2.7 per 10,000 person-years). High-attenuation areas were associated with an increased rate of ILD hospitalization (adjusted hazard ratio, 2.6 per 1-SD increment in high-attenuation areas; 95% confidence interval, 1.9-3.5; P < 0.001), a finding that was stronger among men, African Americans, and Hispanics. High-attenuation areas were also associated with an increased rate of ILD-specific death (adjusted hazard ratio, 2.3; 95% confidence interval, 1.7-3.0; P < 0.001). Our findings were consistent among both smokers and nonsmokers.

Conclusions: Areas of increased lung attenuation are a novel risk factor for ILD hospitalization and mortality. Measurement of high-attenuation areas by screening and diagnostic computed tomography may be warranted in at-risk adults.

Citing Articles

Interstitial Lung Abnormalities: Unraveling the Journey from Incidental Discovery to Clinical Significance.

Gogali A, Kyriakopoulos C, Kostikas K Diagnostics (Basel). 2025; 15(4).

PMID: 40002659 PMC: 11854474. DOI: 10.3390/diagnostics15040509.


Idiopathic Dendriform Pulmonary Ossification Diagnosed by Transbronchial Lung Cryobiopsy: A Case Report.

Komatsu M, Sugiyama F, Todoroki K, Takizawa M, Hanaoka M Cureus. 2025; 17(1):e77955.

PMID: 39996179 PMC: 11848692. DOI: 10.7759/cureus.77955.


Antinuclear antibodies and progression of quantitative interstitial lung changes: The Multi-Ethnic Study of Atherosclerosis (MESA)-Lung Study.

Flack K, George M, Kim J, Hsu J, Podolanczuk A, Hoffman E Respir Med. 2025; 238:107955.

PMID: 39855480 PMC: 11851077. DOI: 10.1016/j.rmed.2025.107955.


Epithelial stem cells from human small bronchi offer a potential for therapy of idiopathic pulmonary fibrosis.

Liu Z, Zheng Q, Li Z, Huang M, Zhong C, Yu R EBioMedicine. 2025; 112:105538.

PMID: 39753035 PMC: 11754162. DOI: 10.1016/j.ebiom.2024.105538.


Machine learning classifier is associated with mortality in interstitial lung disease: a retrospective validation study leveraging registry data.

Selvan K, Reicher J, Muelly M, Kalra A, Adegunsoye A BMC Pulm Med. 2024; 24(1):254.

PMID: 38783245 PMC: 11112769. DOI: 10.1186/s12890-024-03021-w.


References
1.
Washko G, Lynch D, Matsuoka S, Ross J, Umeoka S, Diaz A . Identification of early interstitial lung disease in smokers from the COPDGene Study. Acad Radiol. 2009; 17(1):48-53. PMC: 2790552. DOI: 10.1016/j.acra.2009.07.016. View

2.
Durheim M, Collard H, Roberts R, Brown K, Flaherty K, King Jr T . Association of hospital admission and forced vital capacity endpoints with survival in patients with idiopathic pulmonary fibrosis: analysis of a pooled cohort from three clinical trials. Lancet Respir Med. 2015; 3(5):388-96. PMC: 4760351. DOI: 10.1016/S2213-2600(15)00093-4. View

3.
Putman R, Hatabu H, Araki T, Gudmundsson G, Gao W, Nishino M . Association Between Interstitial Lung Abnormalities and All-Cause Mortality. JAMA. 2016; 315(7):672-81. PMC: 4828973. DOI: 10.1001/jama.2016.0518. View

4.
Araki T, Putman R, Hatabu H, Gao W, Dupuis J, Latourelle J . Development and Progression of Interstitial Lung Abnormalities in the Framingham Heart Study. Am J Respir Crit Care Med. 2016; 194(12):1514-1522. PMC: 5215030. DOI: 10.1164/rccm.201512-2523OC. View

5.
Podolanczuk A, Oelsner E, Barr R, Bernstein E, Hoffman E, Easthausen I . High-Attenuation Areas on Chest Computed Tomography and Clinical Respiratory Outcomes in Community-Dwelling Adults. Am J Respir Crit Care Med. 2017; 196(11):1434-1442. PMC: 5736977. DOI: 10.1164/rccm.201703-0555OC. View